Death
Mostrando 1-12 de 11402 artigos, teses e dissertações.
-
1. É sempre necessário solicitar um eletrocardiograma antes de prescrever um antidepressivo tricíclico?
Não há necessidade absoluta de solicitar eletrocardiograma (ECG) antes de prescrever um antidepressivo tricíclico. Pacientes sem fatores de risco para morte súbita e em uso de doses baixas de tricíclicos (abaixo de 100 mg/dia de amitriptilina, imipramina e clomipramina e abaixo de 62,5 mg/dia de nortriptilina,) não necessitam realizar um ECG antes d
Núcleo de Telessaúde Rio Grande do Sul. Publicado em: 12/06/2023
-
2. Quais orientações devem ser disseminadas aos cuidadores de recém-nascido quanto à morte súbita infantil?
Pais e cuidadores devem ser alertados quanto ao risco de morte súbita de crianças no primeiro ano de vida, sobretudo nos primeiros 6 meses. Devem receber a orientação de que a melhor maneira de prevenir sua ocorrência é colocar a criança para dormir de “barriga para cima” (posição supina), e não de lado ou de bruços (de decúbito lateral ou
Núcleo de Telessaúde NUTES PE. Publicado em: 12/06/2023
-
3. O uso ininterrupto de AAS é indicado para prevenção secundária de Acidente Vascular Cerebral Isquêmico e Infarto Agudo do Miocárdio? Qual a dosagem ideal e o que deve ser avaliado?
Sim, o uso ininterrupto de Ácido Acetil Salicílico (AAS) está indicado na prevenção secundária de Acidente Vascular Cerebral Isquêmico (AVCi) e Infarto Agudo do Miocardio (IAM)
. As pessoas que tomam AAS na prevenção secundária de eventos cardiovasculares, por dois ou mais anos de terapia diária, sofrem menos de IAM, AVCi e morte, de acor
Núcleo de Telessaúde Santa Catarina. Publicado em: 12/06/2023
-
4. Pediatric inflammatory multisystemic syndrome in Brazil: sociodemographic characteristics and risk factors to death
Abstract Objective: To determine the incidence of MIS-C in Brazil, describe the clinical and sociodemographic characteristics of the pediatric population affected by MIS-C and compare mortality and lethality outcomes with isolated Covid-19 and MIS-C cases. Methods: Observational and retrospective cohort study of cases of MIS-C associated with Covid-19 in t
Jornal de Pediatria. Publicado em: 2023
-
5. Growth phenotypes of very low birth weight infants for prediction of neonatal outcomes from a Brazilian cohort: comparison with INTERGROWTH
Abstract Objective: To assess the predictive value of selected growth phenotypes for neonatal morbidity and mortality in preterm infants < 30 weeks and to compare them with INTERGROWTH-21st (IG21). Methods: Retrospective analysis of data from the Brazilian Neonatal Research Network (BNRN) database for very low birth weight (VLBW) at 20 public tertiary-care
Jornal de Pediatria. Publicado em: 2023
-
6. Sickle cell disease related mortality in Brazil, 2000-2018
Abstract Introduction There is a demand to update national mortality trends data related to sickle cell disease (SCD) in Brazil. This study describes causes of death and mortality issues related to SCD using the multiple-cause-of-death methodology. Methods The annual SCD mortality data was extracted from the public databases of the Mortality Information Sy
Hematology, Transfusion and Cell Therapy. Publicado em: 2022
-
7. Discussion of the Brazilian neurologists about sudden unexpected death in epilepsy
SUMMARY OBJECTIVE: This study aimed to evaluate the concept of health professionals affiliated with the Brazilian League of Epilepsy on whether or not to inform patients about the risk factors related to the occurrence of sudden unexpected death in epilepsy. METHODS: A descriptive research of inquiry was conducted with direct survey on the Brazilian neurol
Revista da Associação Médica Brasileira. Publicado em: 2022
-
8. Cardioprotective Effects of Sodium-glucose Cotransporter 2 Inhibitors Regardless of Type 2 Diabetes Mellitus: A Meta-analysis
Abstract Background: Type 2 diabetes mellitus (T2DM) is an independent risk factor for cardiovascular impairment, increasing the rates of atherosclerotic and non-atherosclerotic events. Additionally, adverse kidney events are directly linked with T2DM and cardiovascular diseases. In this context, the sodium-glucose cotransporter 2 inhibitors (SGLT2i) have d
International Journal of Cardiovascular Sciences. Publicado em: 2022
-
9. Risk factors for hospitalization and death due to COVID-19 among frail community-dwelling elderly people: a retrospective cohort study
ABSTRACT BACKGROUND: Advanced age, multiple chronic diseases and frailty have been correlated with worse prognosis among coronavirus disease 2019 (COVID-19) inpatients. OBJECTIVE: To investigate potential risk factors for hospitalization and death due to COVID-19 among frail community-dwelling elderly people. DESIGN AND SETTING: Retrospective cohort study
Sao Paulo Medical Journal. Publicado em: 2022
-
10. Mortality from Cardiovascular Diseases: A Comparative Analysis between the Medical and Non-Medical Populations in Brazil
Abstract Background: Cardiovascular disease (CVD) is the leading cause of death worldwide, including among physicians. Professional peculiarities increase cardiovascular risk in this population, making it relevant to analyze mortality in the medical population (MPop) and non-medical population (NMPop). Objectives: To compare the CVD mortality coefficient (
International Journal of Cardiovascular Sciences. Publicado em: 2022
-
11. Skin-to-skin contact and deaths in newborns weighing up to 1800 grams: a cohort study
Abstract Objective: To evaluate the association between dose of skin-to-skin contact (SSC) per day and initiation time with the occurrence of deaths in newborns with weight up to 1800g. Method: Multicentric cohort in five Brazilian neonatal units, including newborns with a birth weight of ≤1800g. The time of SSC was registered in individual file, by the
Jornal de Pediatria. Publicado em: 2022
-
12. Text Messages to Promote Secondary Prevention after Acute Coronary Syndrome (IMPACS trial)
Abstract Background Short message service (SMS) to promote healthcare improves the control of cardiovascular risk factors, but there is a lack of evidence in low and middle-income countries, particularly after acute coronary syndromes (ACS). Objective This study aims to evaluate whether the use of SMS increases risk factor control after hospital discharg
International Journal of Cardiovascular Sciences. Publicado em: 2022